These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7139969)

  • 21. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New mineralocorticoids and mineralocorticoid-like steroids].
    Sekihara H
    Nihon Rinsho; 1984 Nov; 42(11):2552-6. PubMed ID: 6397623
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings of the symposium Neurogenic Mechanisms in Hypertension. San Diego, California, April 27-28, 1981. Second Annual Conference of the Hypertension Specialized Centers of Research.
    Clin Exp Hypertens A; 1982; 4(4-5):521-848. PubMed ID: 6125280
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aldosterone blockade in essential hypertension].
    Venco A; Grandi AM
    Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aldosterone and 11 beta-hydroxysteroid dehydrogenase: role in arterial hypertension].
    Bonvalet JP
    Rev Prat; 1993 Dec; 43(20 Suppl):18-21. PubMed ID: 8146578
    [No Abstract]   [Full Text] [Related]  

  • 26. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A symposium: Cardiovascular disease in the elderly--etiology, prevention, diagnosis and treatment. February 26-27, 1988, Newport Beach, California.
    Am J Cardiol; 1989 May; 63(16):1H-59H. PubMed ID: 2705393
    [No Abstract]   [Full Text] [Related]  

  • 28. Aldosterone and cardiovascular pathology: from bench to bedside.
    Vintilă M; Băluţă M
    Rom J Intern Med; 2004; 42(1):15-26. PubMed ID: 15529592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and hypokalemia: unusual syndromes.
    Cruz DN; Perazella MA
    Conn Med; 1997 Feb; 61(2):67-75. PubMed ID: 9066195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The importance of aldosterone in the development of edema and hypertension].
    Ratner NA; Gerasimova EN
    Klin Med (Mosk); 1966 Jul; 44(7):13-20. PubMed ID: 5956281
    [No Abstract]   [Full Text] [Related]  

  • 32. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
    Chamontin B; Blanchouin-Emeric N; Amar J; Khatibi F; Vernier I; Bennet A; Aupetit-Faisant B; Salvador M
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Gabow PA
    Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone revisited.
    Haddy FJ
    N Engl J Med; 2004 Nov; 351(20):2131-3; author reply 2131-3. PubMed ID: 15537915
    [No Abstract]   [Full Text] [Related]  

  • 39. The mineralocorticoid hormones in human hypertension. Remarks after receiving the Robert Tigerstedt award.
    Biglieri EG
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):313-8. PubMed ID: 3291898
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rhabdomyolysis and arterial hypertension caused by apparent excess of mineralocorticoids: a case report].
    Sardi A; Geda C; Nerici L; Bertello P
    Ann Ital Med Int; 2002; 17(2):126-9. PubMed ID: 12150047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.